# Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis

> **NCT00828412** · PHASE4 · COMPLETED · sponsor: **Promius Pharma, LLC** · enrollment: 100 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DEVICE:** EpiCeram Skin Barrier Emulsion
- **DRUG:** Desonide Cream 0.05%

## Key facts

- **NCT ID:** NCT00828412
- **Lead sponsor:** Promius Pharma, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2017-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00828412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00828412, "Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00828412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*